BM-221

N/A

Report date: 2023/05/22 10:15:46
NME

Base Information

Drug NameBM-221
Drug Alias NameBM-221
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor 1 agonists
TargetsC5a anaphylatoxin chemotactic receptor 1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A